GoodRx Holdings, Inc. (GDRX)
Nasdaq · Healthcare · Health Information Services
$3.36+2.44%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $1.1B
- P/E (trailing)
- 67.2
- Forward P/E
- 9.5
- 52-week range
- $1.77 – $5.81
- 52-week change
- −25.28%
- EPS (trailing)
- $0.05
- Analyst rating
- 2.6 Hold
- Next earnings
- Nov 3, 2026
Fiscal year to Dec 2025
- Revenue
- $797M (+0.57%)
- Net income
- $30.4M
- Operating margin
- 11.0%
- Diluted EPS
- $0.09
- Free cash flow
- $164M
From the company’s annual report on SEC EDGAR.
About GoodRx Holdings, Inc.
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
Headquarters: Santa Monica, United States · 697 employees · goodrx.com